ES2144355B1 - Compuestos derivados del cromeno. - Google Patents

Compuestos derivados del cromeno.

Info

Publication number
ES2144355B1
ES2144355B1 ES009702718A ES9702718A ES2144355B1 ES 2144355 B1 ES2144355 B1 ES 2144355B1 ES 009702718 A ES009702718 A ES 009702718A ES 9702718 A ES9702718 A ES 9702718A ES 2144355 B1 ES2144355 B1 ES 2144355B1
Authority
ES
Spain
Prior art keywords
sub
compounds derived
chrome
hydrogen
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES009702718A
Other languages
English (en)
Other versions
ES2144355A1 (es
Inventor
Ambros Rafael Foguet
Gener Jordi Bolos
Munoz Aurelio Sacristan
Barenys Josep Castello
Hernandez Jose A Ortiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to ES009702718A priority Critical patent/ES2144355B1/es
Priority to TW087119931A priority patent/TW464650B/zh
Priority to ZA9811217A priority patent/ZA9811217B/xx
Priority to PA19988464301A priority patent/PA8464301A1/es
Priority to BR9807276-5A priority patent/BR9807276A/pt
Priority to IL13157298A priority patent/IL131572A0/xx
Priority to EP98966856A priority patent/EP0970076A1/en
Priority to AU25143/99A priority patent/AU2514399A/en
Priority to US09/380,092 priority patent/US6187793B1/en
Priority to ARP980106728A priority patent/AR017968A1/es
Priority to KR1019997007915A priority patent/KR20000075840A/ko
Priority to CA002282596A priority patent/CA2282596A1/en
Priority to RU99120682/04A priority patent/RU2179556C2/ru
Priority to JP53563099A priority patent/JP2001515517A/ja
Priority to PCT/EP1998/008497 priority patent/WO1999035144A1/en
Priority to PL98335463A priority patent/PL335463A1/xx
Priority to NZ337260A priority patent/NZ337260A/xx
Priority to NO994161A priority patent/NO994161L/no
Publication of ES2144355A1 publication Critical patent/ES2144355A1/es
Application granted granted Critical
Publication of ES2144355B1 publication Critical patent/ES2144355B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos derivados del cromeno de fórmula general (I) donde R significa hidrógeno, CHO, CH sub,2 OR sub,2 , o COOH; R sub,1 significa hidrógeno o CH sub,2 OH; y R sub,2 significa alquilo cuyo número de carbonos está comprendido entre 1 y 4, ambos inclusive, con la condición de que un sustituyente elegido entre R y R sub,1 debe ser hidrógeno, así como sus sales farmacéuticamente aceptables. Se describe también el procedimiento para su obtención y las composiciones farmacéuticas que los contienen. Estos compuestos son nuevos y tienen aplicación en el tratamiento de la psicosis, la esquizofrenia y la alergia.
ES009702718A 1997-12-30 1997-12-30 Compuestos derivados del cromeno. Expired - Lifetime ES2144355B1 (es)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ES009702718A ES2144355B1 (es) 1997-12-30 1997-12-30 Compuestos derivados del cromeno.
TW087119931A TW464650B (en) 1997-12-30 1998-11-30 7-[3-[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy]-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and allergy
ZA9811217A ZA9811217B (en) 1997-12-30 1998-12-08 7-[3-[4(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and allergy.
PA19988464301A PA8464301A1 (es) 1997-12-30 1998-12-10 Compuestos derivados del cromeno
JP53563099A JP2001515517A (ja) 1997-12-30 1998-12-29 ７−〔（ピペリジン−１−イル）−プロポキシ〕−クロメン−４−オン誘導体、それらの製造およびそれらの医薬としての使用
EP98966856A EP0970076A1 (en) 1997-12-30 1998-12-29 7-[(piperidin-1-yl)- propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
AU25143/99A AU2514399A (en) 1997-12-30 1998-12-29 7-((piperidin-1-yl)-propoxy)-chromen-4-one derivatives, their preparation and their pharmaceutical use
US09/380,092 US6187793B1 (en) 1997-12-30 1998-12-29 7-[(Piperidin-1-YL)-Propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
ARP980106728A AR017968A1 (es) 1997-12-30 1998-12-29 Compuesto derivado del cromeno, procedimiento de obtencion de dicho compuesto y composicion farmaceutica para el tratamiento de la psicosis, laesquizofrenia y la alergia
KR1019997007915A KR20000075840A (ko) 1997-12-30 1998-12-29 7-[(피페리딘-1-와이엘)프로폭시]-크로멘-4-원 유도체, 그 제조및 그 약학적 이용
BR9807276-5A BR9807276A (pt) 1997-12-30 1998-12-29 Derivados de 7-[3-[4-(6-fluorobenzo[d] isoxazol 3-il ) piperidin-1-il] propóxi]- cromen-4-ona, sua preparação e seu uso no tratamento de psicose, esquizofrenia a alegria
RU99120682/04A RU2179556C2 (ru) 1997-12-30 1998-12-29 Производные 7-[3-[4-(6-фторбензо[d]изоксазол-3-ил)пиперидин-1-ил]пропокси]-хромен-4-она, способ их получения, фармацевтическая композиция для ингибирования d2-,5-ht2a- и h1-рецепторов и способ ингибирования d2-,5-ht2a- и h1-рецепторов при лечении психоза и шизофрении
IL13157298A IL131572A0 (en) 1997-12-30 1998-12-29 7-[(Piperidin-1-yl)- propoxy]- chromen -4-one derivatives their preparation and their pharmaceutical use
PCT/EP1998/008497 WO1999035144A1 (en) 1997-12-30 1998-12-29 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
PL98335463A PL335463A1 (en) 1997-12-30 1998-12-29 Derivatives of 7-[3-[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy]-chromen-4-one, their production and application in treating psychosis, schisophrenia and allergy
NZ337260A NZ337260A (en) 1997-12-30 1998-12-29 7-[3-[4-(6-fluorobenzo[d]isoxazol-3-yl) piperidin-1-yl]-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
CA002282596A CA2282596A1 (en) 1997-12-30 1998-12-29 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
NO994161A NO994161L (no) 1997-12-30 1999-08-27 7-[(piperidin-1-yl)-propoksy]-kromen-4-onderivater, deres fremstilling og deres farmasöytiske anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009702718A ES2144355B1 (es) 1997-12-30 1997-12-30 Compuestos derivados del cromeno.

Publications (2)

Publication Number Publication Date
ES2144355A1 ES2144355A1 (es) 2000-06-01
ES2144355B1 true ES2144355B1 (es) 2001-01-01

Family

ID=8301662

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009702718A Expired - Lifetime ES2144355B1 (es) 1997-12-30 1997-12-30 Compuestos derivados del cromeno.

Country Status (18)

Country Link
US (1) US6187793B1 (es)
EP (1) EP0970076A1 (es)
JP (1) JP2001515517A (es)
KR (1) KR20000075840A (es)
AR (1) AR017968A1 (es)
AU (1) AU2514399A (es)
BR (1) BR9807276A (es)
CA (1) CA2282596A1 (es)
ES (1) ES2144355B1 (es)
IL (1) IL131572A0 (es)
NO (1) NO994161L (es)
NZ (1) NZ337260A (es)
PA (1) PA8464301A1 (es)
PL (1) PL335463A1 (es)
RU (1) RU2179556C2 (es)
TW (1) TW464650B (es)
WO (1) WO1999035144A1 (es)
ZA (1) ZA9811217B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051735A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
CN102206214B (zh) * 2011-04-07 2014-03-12 华中科技大学 苯并吡喃酮类衍生物及其应用
JP5608873B2 (ja) * 2011-05-18 2014-10-15 ラクオリア創薬株式会社 ４−｛［４−（｛［４−（２，２，２−トリフルオロエトキシ）−１，２−ベンズイソオキサゾール−３−イル］オキシ｝メチル）ピペリジン−１−イル］メチル｝−テトラヒドロ−２ｈ−ピラン−４−カルボン酸の多形形態
CN103694233B (zh) * 2013-12-10 2016-08-17 沈阳药科大学 苯并异噁唑类化合物及其应用
CN105153246B (zh) * 2015-08-05 2018-05-25 广州嘉德乐生化科技有限公司 一种蔗糖脂肪酸酯的制备方法及其乳饮料组合物
CN111320619A (zh) * 2018-12-17 2020-06-23 江苏恩华药业股份有限公司 一种类酰胺类衍生物的杂质及用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3117389A1 (de) * 1981-05-02 1982-11-18 Boehringer Mannheim Gmbh, 6800 Mannheim Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4678787A (en) * 1985-01-30 1987-07-07 Warner-Lambert Company 4H-1-benzopyran-4-ones and their sulfur containing analogs
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
JP3193508B2 (ja) * 1993-03-05 2001-07-30 興和株式会社 ピペリジン誘導体
ES2074966B1 (es) * 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
ES2144355A1 (es) 2000-06-01
US6187793B1 (en) 2001-02-13
CA2282596A1 (en) 1999-07-15
AR017968A1 (es) 2001-10-24
ZA9811217B (en) 1999-07-14
KR20000075840A (ko) 2000-12-26
RU2179556C2 (ru) 2002-02-20
JP2001515517A (ja) 2001-09-18
EP0970076A1 (en) 2000-01-12
NZ337260A (en) 2000-09-29
AU2514399A (en) 1999-07-26
NO994161L (no) 1999-10-25
TW464650B (en) 2001-11-21
WO1999035144A1 (en) 1999-07-15
IL131572A0 (en) 2001-01-28
PL335463A1 (en) 2000-04-25
PA8464301A1 (es) 2000-09-29
NO994161D0 (no) 1999-08-27
BR9807276A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2185665T3 (es) Derivados de benzofurano como antagonistas de taquicininas.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
AR038136A1 (es) Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
UY27918A1 (es) Derivados de benzodioxol
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
AR039743A1 (es) Fenilbenzamidas y su uso para el control de microoganismos indeseados
PA8583201A1 (es) Nuevos compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf)
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
CR7612A (es) Compuestos de fenilsulfonamida sustituida inhibidores de la produccion de beta-amiloide
ES2175155T3 (es) Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
ES2144355B1 (es) Compuestos derivados del cromeno.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
PE132099A1 (es) Nuevos derivados de la vitamina d3
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2062442T3 (es) Nuevos derivados de tetrahidro-5,6,7,8 naftalenol-1, su procedimiento de preparacion y su utilizacion como agentes antioxidantes en composiciones cosmeticas y farmaceuticas que los contienen.
SV2002000418A (es) Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb
UY26498A1 (es) Pirroles sustituidos
PA8593601A1 (es) Nuevos compuestos farmaceuticos
MX9204220A (es) Bencimidazoles.
ES2103904T3 (es) Compuestos derivados de las beta-carbolinas ligantes del receptor de las benzodiacepinas que tienen un efecto agonista inverso y antagonista con respecto a las benzodiacepinas y medicamentos que los contienen.
MX9102192A (es) Mejoras en compuestos de piperazinoalquilbenzoxazina y piperazinoalquilbenzotiazin sustituidos con un heterociclo, asi como procedimiento para su preparacion.
ES2145926T3 (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
ES2103237B1 (es) Nuevo compuesto derivado del cromeno.
ES2101620B1 (es) Nuevo compuesto derivado del cromeno.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000601

Kind code of ref document: A1

Effective date: 20000601